Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | Patent Number 10912751

US 10912751 B2
Application Number15558084
Publication NumberUS 20180064671 A1
Pendency4 years, 11 months, 3 days
Filled DateMar 14, 2016
Priority DateMar 13, 2015
Publication DateMar 8, 2018
Expiration DateMar 12, 2035
Inventor/ApplicantsDiane Elaine MacDougall
Roger Schofield Newton
Noah Laban Rosenberg
ExaminesKANTAMNENI, SHOBHA
Art Unit1627
Technology Center1600
Assignments
Esperion Therapeutics Inc.
Current
Esperion Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.